• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.低维生素C血症在转基因小鼠中诱发动脉粥样硬化和脂蛋白(a)的血管沉积。
Am J Cardiovasc Dis. 2015 Mar 20;5(1):53-62. eCollection 2015.
2
Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.脂蛋白(a)和维生素C会损害Lp(a)+;Gulo-/-小鼠乳腺癌肿瘤的发展。
Int J Oncol. 2016 Sep;49(3):895-902. doi: 10.3892/ijo.2016.3597. Epub 2016 Jul 1.
3
Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig.低抗坏血酸豚鼠动脉粥样硬化病变中脂蛋白(a)积累的免疫学证据。
Proc Natl Acad Sci U S A. 1990 Dec;87(23):9388-90. doi: 10.1073/pnas.87.23.9388.
4
Age and Dietary Vitamin C Intake Affect Brain Physiology in Genetically Modified Mice Expressing Human Lipoprotein(A) and Unable to Synthesize Vitamin C.年龄和膳食维生素C摄入量影响表达人脂蛋白(A)且无法合成维生素C的转基因小鼠的脑生理学。
Curr Aging Sci. 2021;14(3):223-234. doi: 10.2174/1874609814666210706170326.
5
Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.评估脂蛋白(a)在动脉粥样硬化和主动脉瓣狭窄中因果作用的实验动物模型
Cardiovasc Drugs Ther. 2016 Feb;30(1):75-85. doi: 10.1007/s10557-015-6634-1.
6
[New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].[关于脂蛋白(a)的新数据:一个奇特的分子还是一个因果性心血管危险因素?]
Rev Med Brux. 2010 May-Jun;31(3):171-6.
7
[Lipoprotein Lp(a) and CETP (cholesterol ester transfer protein): contribution of transgenic mice].[脂蛋白Lp(a)与胆固醇酯转运蛋白(CETP):转基因小鼠的作用]
Bull Acad Natl Med. 1994 Mar;178(3):427-34; discussion 434-6.
8
Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?对脂蛋白(a)生理学和致病性的新见解:问题多于答案?
Cardiovasc Hematol Disord Drug Targets. 2006 Dec;6(4):267-78. doi: 10.2174/187152906779010764.
9
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.脂蛋白分离术是降低升高的脂蛋白(a)水平的最佳治疗选择。
Clin Res Cardiol Suppl. 2019 Apr;14(Suppl 1):33-38. doi: 10.1007/s11789-019-00094-4.
10
Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.在转基因小鼠模型中,血浆羧基酯脂肪酶活性调节含载脂蛋白B的脂蛋白代谢。
Metabolism. 2008 Oct;57(10):1361-8. doi: 10.1016/j.metabol.2008.05.003.

引用本文的文献

1
Vitamin C in Cardiovascular Disease: From Molecular Mechanisms to Clinical Evidence and Therapeutic Applications.维生素C与心血管疾病:从分子机制到临床证据及治疗应用
Antioxidants (Basel). 2025 Apr 23;14(5):506. doi: 10.3390/antiox14050506.
2
Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study.亚热带地区血浆维生素 C 不足的患病率及其预测因素及其与心血管疾病危险因素的关系:一项回顾性横断面研究。
Nutrients. 2022 Mar 6;14(5):1108. doi: 10.3390/nu14051108.
3
Dietary Vitamin C and Age-Induced Lipid and Hormonal Metabolic Changes in a Humanized Mouse Model Not Synthesizing Vitamin C and Producing Lipoprotein(a) [Gulo (-/-); Lp(a)+].在一种不合成维生素C且产生脂蛋白(a)的人源化小鼠模型[古洛糖酸内酯氧化酶基因敲除(-/-);脂蛋白(a)阳性]中,膳食维生素C与年龄诱导的脂质和激素代谢变化
J Nutr Metab. 2021 Jun 15;2021:5591697. doi: 10.1155/2021/5591697. eCollection 2021.
4
Total Vitamin C, Ascorbic Acid, Dehydroascorbic Acid, Antioxidant Properties, and Iron Content of Underutilized and Commonly Consumed Fruits in Sri Lanka.斯里兰卡未充分利用和常见食用水果中的总维生素C、抗坏血酸、脱氢抗坏血酸、抗氧化特性及铁含量
Int J Food Sci. 2020 Aug 20;2020:4783029. doi: 10.1155/2020/4783029. eCollection 2020.
5
Vitamin C inhibits the calcification process in human vascular smooth muscle cells.维生素C抑制人类血管平滑肌细胞中的钙化过程。
Am J Cardiovasc Dis. 2020 Jun 15;10(2):108-116. eCollection 2020.
6
The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway.利用营养保健品对抗动脉粥样硬化:Notch 通路的作用。
Oxid Med Cell Longev. 2019 May 2;2019:5470470. doi: 10.1155/2019/5470470. eCollection 2019.
7
Dietary antioxidants remodel DNA methylation patterns in chronic disease.膳食抗氧化剂重塑慢性病中的DNA甲基化模式。
Br J Pharmacol. 2020 Mar;177(6):1382-1408. doi: 10.1111/bph.14888. Epub 2019 Dec 23.
8
Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.脂蛋白(a)和维生素C会损害Lp(a)+;Gulo-/-小鼠乳腺癌肿瘤的发展。
Int J Oncol. 2016 Sep;49(3):895-902. doi: 10.3892/ijo.2016.3597. Epub 2016 Jul 1.
9
Inhibition of collagen synthesis by select calcium and sodium channel blockers can be mitigated by ascorbic acid and ascorbyl palmitate.某些钙通道阻滞剂和钠通道阻滞剂对胶原蛋白合成的抑制作用可通过抗坏血酸和棕榈酸抗坏血酸酯来减轻。
Am J Cardiovasc Dis. 2016 May 18;6(2):26-35. eCollection 2016.
10
The effect of multiple micronutrient supplementation on quality of life in patients with symptomatic heart failure secondary to ischemic heart disease: a prospective case series clinical study.多种微量营养素补充剂对缺血性心脏病继发症状性心力衰竭患者生活质量的影响:一项前瞻性病例系列临床研究。
Am J Cardiovasc Dis. 2015 Sep 15;5(3):146-52. eCollection 2015.

本文引用的文献

1
Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis.定量脂蛋白免疫电泳法验证脂蛋白(a)颗粒浓度测定。
Clin Chim Acta. 2015 Jan 15;439:219-24. doi: 10.1016/j.cca.2014.10.013. Epub 2014 Oct 16.
2
Lipoprotein(a): resurrected by genetics.脂蛋白(a):遗传学复活。
J Intern Med. 2013 Jan;273(1):6-30. doi: 10.1111/j.1365-2796.2012.02592.x. Epub 2012 Nov 12.
3
A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.人类的一种新血清类型系统——LP系统。
Acta Pathol Microbiol Scand. 1963;59:369-82. doi: 10.1111/j.1699-0463.1963.tb01808.x.
4
Aortic wall damage in mice unable to synthesize ascorbic acid.无法合成抗坏血酸的小鼠的主动脉壁损伤
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):841-6. doi: 10.1073/pnas.97.2.841.
5
Transgenic mice expressing a human apolipoprotein[a] allele.
J Lipid Res. 1999 Jun;40(6):994-1006.
6
Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein B.
J Biol Chem. 1998 Jan 9;273(2):1247-51. doi: 10.1074/jbc.273.2.1247.
7
Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.
Nature. 1994 Aug 11;370(6489):460-2. doi: 10.1038/370460a0.
8
Binding of recombinant apolipoprotein(a) to extracellular matrix proteins.
Arterioscler Thromb. 1994 Nov;14(11):1792-8. doi: 10.1161/01.atv.14.11.1792.
9
How LDL receptors influence cholesterol and atherosclerosis.低密度脂蛋白受体如何影响胆固醇和动脉粥样硬化。
Sci Am. 1984 Nov;251(5):58-66. doi: 10.1038/scientificamerican1184-58.
10
Endothelial changes produced by ascorbic acid deficiency in guinea pigs.
Arch Pathol. 1965 Oct;80(4):371-6.

低维生素C血症在转基因小鼠中诱发动脉粥样硬化和脂蛋白(a)的血管沉积。

Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.

作者信息

Cha John, Niedzwiecki Aleksandra, Rath Matthias

机构信息

Dr. Rath Research Institute Santa Clara, CA, USA.

出版信息

Am J Cardiovasc Dis. 2015 Mar 20;5(1):53-62. eCollection 2015.

PMID:26064792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4447075/
Abstract

Lipoprotein(a), a variant of LDL carrying the adhesive glycoprotein apo(a), is a leading risk factor for cardiovascular disease. Lipoprotein(a) (Lp(a)) is found in humans and subhuman primates but rarely in lower mammals. Better understanding of the evolutionary advantage of this molecule should elucidate its physiological role. We developed a new mouse model with two characteristics of human metabolism: the expression of Lp(a) and the lack of endogenous ascorbate (vitamin C) production. We show that dietary deficiency of ascorbate increases serum levels of Lp(a). Moreover, chronic hypoascorbemia and complete depletion of ascorbate (scurvy) leads to Lp(a) accumulation in the vascular wall and parallels atherosclerotic lesion development. The results suggest that dietary ascorbate deficiency is a risk factor for atherosclerosis independent of dietary lipids. We provide support for the concept that Lp(a) functions as a mobile repair molecule compensating for the structural impairment of the vascular wall, a morphological hallmark of hypoascorbemia and scurvy.

摘要

脂蛋白(a)是低密度脂蛋白的一种变体,携带黏附性糖蛋白载脂蛋白(a),是心血管疾病的主要危险因素。脂蛋白(a)(Lp(a))存在于人类和灵长类动物中,但在低等哺乳动物中很少见。更好地理解这种分子的进化优势应该能够阐明其生理作用。我们开发了一种具有人类代谢两个特征的新型小鼠模型:Lp(a)的表达和内源性抗坏血酸(维生素C)生成的缺乏。我们发现,饮食中缺乏抗坏血酸会增加血清Lp(a)水平。此外,慢性低抗坏血酸血症和抗坏血酸完全耗尽(坏血病)会导致Lp(a)在血管壁中积累,并与动脉粥样硬化病变发展平行。结果表明,饮食中缺乏抗坏血酸是独立于饮食脂质的动脉粥样硬化危险因素。我们支持这样的观点,即Lp(a)作为一种移动修复分子发挥作用,补偿血管壁的结构损伤,这是低抗坏血酸血症和坏血病的形态学特征。